“…Another limitation of the study is that we did not evaluate the association between homocysteine levels and Results are the mean±SD or mean±SEM for differences or n (%) as stated a The CC genotype had significantly higher rate of prevalent fracture than the AA and AC genotypes, P=0.024 (chi-square test) b Analysis adjusted for baseline age and weight, 1 year hip BMD, prevalent fracture, calcium treatment, and compliance with study tablets some medications, such as anti-epileptic, lipid-lowering, and antihypertensive drugs, that have been reported to influence homocysteine levels [40,41]. Consistent with previous analyses [15,42,43], an increased plasma homocysteine level was observed in those with the MTHFR C677T TT genotype and either low folate intake or low riboflavin intake. These data support that this polymorphism impairs the MTHFR enzyme activity and thus the conversion of homocysteine to methionine, especially in the presence of suboptimal levels of dietary folate and riboflavin, which are both necessary for the conversion.…”